HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Tsunoda Selected Research

Type I Tumor Necrosis Factor Receptors

5/2016Generation of a sensitive TNFR2-specific murine assays system.
2/2010Creation of an improved mutant TNF with TNFR1-selectivity and antagonistic activity by phage display technology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Tsunoda Research Topics

Disease

15Neoplasms (Cancer)
10/2019 - 01/2000
6Carcinoma (Carcinomatosis)
01/2010 - 04/2000
4Leukemia
05/2007 - 03/2001
3Colorectal Neoplasms (Colorectal Cancer)
03/2012 - 01/2000
3Adenocarcinoma
01/2008 - 12/2000
3Colonic Neoplasms (Colon Cancer)
01/2001 - 01/2000
3Fibrosarcoma
12/2000 - 01/2000
2Autoimmune Diseases (Autoimmune Disease)
05/2016 - 02/2010
2Neoplasm Metastasis (Metastasis)
03/2012 - 08/2006
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
09/2010 - 03/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2008 - 01/2006
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2007 - 03/2001
2Lymphoma (Lymphomas)
09/2002 - 03/2000
2Philadelphia Chromosome
09/2002 - 04/2001
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2001 - 03/2001
1Stroke (Strokes)
12/2021
1Atopic Dermatitis (Atopic Eczema)
01/2016
1Hypersensitivity (Allergy)
01/2016
1Anaphylaxis (Anaphylactic Shock)
01/2016
1Lung Neoplasms (Lung Cancer)
12/2013
1Esophageal Neoplasms (Esophageal Cancer)
08/2012
1Prostatic Neoplasms (Prostate Cancer)
03/2012
1Infections
09/2010
1Acute Promyelocytic Leukemia
09/2010
1Crohn Disease (Crohn's Disease)
02/2010
1Rheumatoid Arthritis
02/2010
1Thrombocytopenia (Thrombopenia)
01/2010
1Esophageal Squamous Cell Carcinoma
08/2006
1Lymphatic Metastasis
08/2006
1Heart Diseases (Heart Disease)
06/2006
1Shock
06/2006
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2006
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2006
1Small Cell Carcinoma
01/2006
1IGA Glomerulonephritis (IGA Nephropathy)
07/2005
1Burkitt Lymphoma (Burkitt's Lymphoma)
09/2002
1B-Cell Leukemia (Leukemia, B Cell)
09/2002
1T-Cell Leukemia (Leukemia, T Cell)
09/2002
1Mixed Connective Tissue Disease (MCTD)
11/2001

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
05/2016 - 06/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 01/2000
4Proteins (Proteins, Gene)FDA Link
12/2013 - 07/2005
4Methotrexate (Mexate)FDA LinkGeneric
05/2007 - 01/2001
3raltitrexed (D 1694)IBA
01/2001 - 01/2000
2Type II Tumor Necrosis Factor ReceptorsIBA
05/2016 - 02/2010
2Type I Tumor Necrosis Factor ReceptorsIBA
05/2016 - 02/2010
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
05/2016 - 02/2010
2Immunoglobulin G (IgG)IBA
01/2016 - 12/2000
2Biomarkers (Surrogate Marker)IBA
12/2013 - 03/2012
2nedaplatinIBA
01/2010 - 01/2008
2Cisplatin (Platino)FDA LinkGeneric
06/2009 - 04/2000
2Cytarabine (Cytosar-U)FDA LinkGeneric
05/2007 - 09/2002
2Vincristine (Oncovin)FDA LinkGeneric
05/2007 - 04/2001
2DNA (Deoxyribonucleic Acid)IBA
06/2006 - 03/2001
2Antineoplastic Agents (Antineoplastics)IBA
01/2006 - 01/2001
2Thymidylate SynthaseIBA
01/2001 - 01/2000
2Monoclonal AntibodiesIBA
12/2000 - 03/2000
2Immunoconjugates (Immunoconjugate)IBA
12/2000 - 03/2000
2AntigensIBA
12/2000 - 03/2000
2Conditioned Culture MediaIBA
02/2000 - 01/2000
1EphrinsIBA
10/2019
1AllergensIBA
01/2016
1Immunoglobulin E (IgE)IBA
01/2016
1ErbB Receptors (EGF Receptor)IBA
12/2013
1rho-Specific Guanine Nucleotide Dissociation InhibitorsIBA
03/2012
1Guanine Nucleotide Dissociation Inhibitors (GDIs)IBA
03/2012
1Arsenic Trioxide (Trisenox)FDA Link
09/2010
1PlatinumIBA
01/2010
1Indicators and Reagents (Reagents)IBA
01/2010
1ParaquatIBA
06/2009
1HerbicidesIBA
06/2009
1Silicon Dioxide (Silica)FDA LinkGeneric
06/2009
1CosmeticsIBA
06/2009
1Etoposide (VP 16)FDA LinkGeneric
05/2007
1midostaurinIBA
05/2007
1Mitoxantrone (Novantrone)FDA LinkGeneric
05/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2007
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
05/2007
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2007
1Tyrosine (L-Tyrosine)FDA Link
05/2007
1Nerve Growth Factor (NGF)IBA
08/2006
1LuciferasesIBA
06/2006
1Biological ProductsIBA
01/2006
1Tyrosine Kinase InhibitorsIBA
01/2006
1mizoribineIBA
07/2005
1Prednisolone (Predate)FDA LinkGeneric
11/2001
1ThrombinFDA Link
09/2001
1Transforming Growth Factor beta (TGF-beta)IBA
09/2001

Therapy/Procedure

5Radiotherapy
01/2010 - 02/2000
4Drug Therapy (Chemotherapy)
09/2010 - 02/2000
2Chemoradiotherapy
01/2010 - 01/2008
2Therapeutics
01/2006 - 03/2000
1Activities of Daily Living (ADL)
12/2021
1Medical Day Care (Partial Hospitalization)
12/2021
1Lymph Node Excision (Lymph Node Dissection)
08/2012
1Neoadjuvant Therapy
08/2012
1Esophagectomy
08/2012
1Catheters
06/2006
1Molecular Targeted Therapy
01/2006
1Aftercare (After-Treatment)
03/2005